![Thomas Denny](/sites/default/files/styles/freeform_scaled/public/2023-01/denny.thomas.magnify.png?itok=N-lt_Crq)
As chief operating officer at the Duke Human Vaccine Institute (DHVI), Thomas Denny is in the unique position of helping people fight flu and HIV, developing the next generation of COVID-19 vaccines, and all the while leading an annual 120 million enterprise.